This paper is in the following e-collection/theme issue:

Digital Health Reviews (1178) Telehealth and Telemonitoring (1557) Digital Health, Telehealth and e-Innovation in Clinical Settings (340) Clinical Communication, Electronic Consultation and Telehealth (542)

Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50090, first published .
Effectiveness of Telemedicine for Musculoskeletal Disorders: Umbrella Review

Effectiveness of Telemedicine for Musculoskeletal Disorders: Umbrella Review

Effectiveness of Telemedicine for Musculoskeletal Disorders: Umbrella Review

Authors of this article:

Silvia Bargeri1 Author Orcid Image ;   Greta Castellini1 Author Orcid Image ;   Jacopo Antonino Vitale2 Author Orcid Image ;   Stefania Guida1 Author Orcid Image ;   Giuseppe Banfi3, 4 Author Orcid Image ;   Silvia Gianola1 Author Orcid Image ;   Federico Pennestrì3 Author Orcid Image
Article Authors Cited by (1) Tweetations (6) Metrics

    Review

    1Unità di Epidemiologia Clinica, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy

    2Spine Center, Schulthess Klinik, Zürich, Switzerland

    3IRCCS Istituto Ortopedico Galeazzi, Milan, Italy

    4Università Vita-Salute San Raffaele, Milan, Italy

    Corresponding Author:

    Greta Castellini, PhD

    Unità di Epidemiologia Clinica

    IRCCS Istituto Ortopedico Galeazzi

    Via Cristina Belgioioso, 173

    Milan, 20161

    Italy

    Phone: 39 02 8350 2260

    Email: greta.castellini@grupposandonato.it


    Background: Several systematic reviews (SRs) assessing the use of telemedicine for musculoskeletal conditions have been published in recent years. However, the landscape of evidence on multiple clinical outcomes remains unclear.

    Objective: We aimed to summarize the available evidence from SRs on telemedicine for musculoskeletal disorders.

    Methods: We conducted an umbrella review of SRs with and without meta-analysis by searching PubMed and EMBASE up to July 25, 2022, for SRs of randomized controlled trials assessing telemedicine. We collected any kind of patient-reported outcome measures (PROMs), patient-reported experience measures (PREMs), and objective measures, including direct and indirect costs. We assessed the methodological quality with the AMSTAR 2 tool (A Measurement Tool to Assess systematic Reviews 2). Findings were reported qualitatively.

    Results: Overall, 35 SRs published between 2015 and 2022 were included. Most reviews (n=24, 69%) were rated as critically low quality by AMSTAR 2. The majority of reviews assessed “telerehabilitation” (n=29) in patients with osteoarthritis (n=13) using PROMs (n=142 outcomes mapped with n=60 meta-analyses). A substantive body of evidence from meta-analyses found telemedicine to be beneficial or equal in terms of PROMs compared to conventional care (n=57 meta-analyses). Meta-analyses showed no differences between groups in PREMs (n=4), while objectives measures (ie, “physical function”) were mainly in favor of telemedicine or showed no difference (9/13). All SRs showed notably lower costs for telemedicine compared to in-person visits.

    Conclusions: Telemedicine can provide more accessible health care with noninferior results for various clinical outcomes in comparison with conventional care. The assessment of telemedicine is largely represented by PROMs, with some gaps for PREMs, objective measures, and costs.

    Trial Registration: PROSPERO CRD42022347366; https://osf.io/pxedm/

    J Med Internet Res 2024;26:e50090

    doi:10.2196/50090

    Keywords

    telemedicine; systematic review; patient-reported outcomes measures; PROMs; patient-reported experience measures; PREMs; rehabilitation; musculoskeletal disorder; condition; musculoskeletal; patient-reported; telerehabilitation; orthopedics; meta-analyses; osteoarthritis; accessibility; health care 


    Telemedicine is a broad term encompassing many applications, such as diagnostic asynchronous evaluation, continuous monitoring using biosensors, and synchronous video consultations, including multiple variations on each theme. This definition includes “telerehabilitation,” “health technologies,” “digital medicine,” and similar keywords [1,2]. During the COVID-19 pandemic, the spread of smart devices and accessible internet connections made telemedicine grow exponentially, become increasingly popular, and be tested for many health conditions [3,4]. Musculoskeletal disorders usually require multidisciplinary and multifacility treatment throughout different settings and providers (physiotherapy, rehabilitation, prehabilitation, and orthopedics; inpatient, outpatient, and home); therefore, the adoption of telemedicine can improve clinical and patient-reported outcomes along with organizational arrangements and cost savings [5,6]. Telemedicine in rehabilitation first appeared in a scientific publication in 1998 [7]; rehabilitation is an old branch of medicine, and in the last 20 years, new telemedicine practices have been developed showing an interest in understanding its effectiveness. However, there is not yet a universal definition of telemedicine nor a consensus on its effects.

    In addition, in recent years, an increasing number of studies have used patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) to evaluate telemedicine services [8]. With the increasing maturity of telemedicine applications and higher evidence levels, the use of PROMs has increased. PREMs in turn are useful to describe the health care service experience from the perspective of patients [9-11] in order to identify real-world factors (eg, organizational, relational, environmental) that may improve or hamper the access to, quality of, and safety of care [12]: in the case of telemedicine, the user-friendliness of a certain technology, its actual functioning in ordinary settings (eg, considering backlogs and poor internet connections), the clarity of the instructions received, and the degree of interoperability among different providers (health care facilities, professionals, and technology suppliers). Otherwise, excellent technical care may be wasted by lack of compliance, poor health literacy, and insufficient patient engagement.

    Different systematic reviews (SRs) [13-15] have been published examining different types of telemedicine solutions in specific musculoskeletal populations. However, it is crucial to investigate evidence on not just a single question but across multiple questions pertaining to a specific topic [16]. This emphasizes the importance of providing the best available evidence on the effectiveness of telemedicine and telerehabilitation in the entire musculoskeletal field, encompassing all telemedicine applications.

    The aim of this umbrella review is to explore the effectiveness of telemedicine and rehabilitation in the treatment of musculoskeletal conditions in terms of physical impairment, function, health-related quality of life (HRQoL), adverse events, adherence, and costs, including PROMs and PREMs. This would help professionals improve decision-making and yield better clinical outcomes for patients.


    Study Design

    We conducted an umbrella review according to the Cochrane Handbook’s chapter on overviews of reviews and the JBI Manual for Evidence Synthesis. Reviews of SRs are referred to by several different names in the scientific literature, including “umbrella reviews,” “overviews of reviews,” “reviews of reviews,” “summaries of systematic reviews,” and “synthesis of reviews” [17,18]. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [19] guidelines for the flow chart and the Preferred Reporting Items for Overviews of Reviews (PRIOR) [20,21] as a reporting checklist. The review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) database (CRD42022347366).

    Criteria for Considering Reviews for Inclusion

    According to Cochrane’s definition, an SR is a review of the literature that “attempts to identify, appraise and synthesize all the empirical evidence that meets pre-specified eligibility criteria to answer a specific research question by using explicit, systematic methods that are selected with a view aimed at minimizing bias, producing more reliable findings to inform decision making” [22]. In this umbrella review, we considered inclusion criteria according to the PICOS (population, intervention, comparison, outcomes, study design) format: patients with any musculoskeletal or orthopedic condition (population); any kind of interventions based on advanced technology systems named as “telemedicine,” “telerehabilitation,” “health technologies” and “digital medicine,” delivered both in synchronous and asynchronous modalities (intervention); in-person treatment or usual care or no treatment (comparison); PROMs, PREMs, or objective measures (outcomes); SRs of randomized controlled trials (RCTs) (study design).

    SRs were excluded if they assessed (1) observational studies, (2) mixed populations (eg, if they combined effects for cardiovascular and musculoskeletal patients, or if it was not possible to separate data for a population of interest, such as musculoskeletal patients), or (3) interventions that aimed to configure technical aspects of devices and apps.

    Main Outcomes

    We considered outcomes related to the following domains: physical impairment, function, health-related quality of life (HRQoL), adverse events, and adherence to therapy or care pathways, expressed as the following categories: PROMs, PREMs, or objective measurements. PROMs are used to assess a patient’s health status at a particular point in time (eg, common symptoms, pain, stiffness, HRQoL, and disease-specific interference with domestic activities and leisure time). Furthermore, we considered PREMs as any patient-reported information about the experience of treatment (eg, inclusivity of a technology, adequate communication with health care professionals, availability of professionals, possibility to ask questions, clarity of information received, spared visits to hospital, access to treatment, and perceived safety). Costs related to treatments were also collected.

    Search Strategy

    A search of SRs was performed in PubMed and Embase from inception to July 25, 2022. The search was restricted to English-language publications. No restriction on year was applied (Multimedia Appendix 1 [8,23], Table S1).

    Data Extraction (Selection and Coding)

    Two independent reviewers consulted information screening sources by title and abstract. The full text of relevant studies was downloaded and evaluated for final inclusion according to the inclusion criteria. Any conflict was resolved through discussion. EndNote (version 20; Clarivate) and Rayyan (Qatar Computing Research Institute) were used to manage the study selection phase. The selection process is shown in the PRISMA flow chart [24].

    Two independent reviewers extracted general characteristics of the SRs (eg, country, funding, and conflicts of interest), population characteristics, interventions, comparisons, and outcomes. Patient populations were classified according to the International Classification of Diseases, 10th revision (ICD-10) codes for diseases of the musculoskeletal system and connective tissue (M00-M99) [25].

    Interventions were classified into three categories, building on a published taxonomy [8]: (1) teleconsultation (providing health care over a distance), telediagnostics (identifying diseases over a distance), and telemonitoring (collecting data over a distance to allow medical decisions); (2) telerehabilitation (collecting data over a distance to help patients cope with the long-term consequences of disease or impairment); and (3) digital self-management (to promote patient health responsibility and encourage health literacy).

    Outcomes were also classified into subgroups for 3 categories: PROMs, PREMs, and objective outcomes. Among PROMs, we examined the following outcome domains: pain, HRQoL, physical function, social function, emotional function, cognitive function, health literacy, side effects, and adherence. We categorized PREMs into 2 outcome domains: treatment and technology. In Multimedia Appendix 1 [8,23], Table S2, we report all details about PROM and PREM taxonomy [8].

    Objective measures were mapped into the same categories (eg, physical function) and costs.

    Quantitative results were extracted from meta-analyses if reviews included more than 1 study in each analysis. For continuous outcomes, we extracted mean difference (MD) or standardized mean difference (SMD) with their 95% CIs. For binary outcomes, we extracted odds ratios (ORs) or relative risks (RRs) with their 95% CIs. In absence of quantitative syntheses, results were reported descriptively.

    Risk of Bias (Quality) Assessment

    The methodological quality of reviews was assessed using AMSTAR 2 (A Measurement Tool to Assess systematic Reviews 2) [26]. It consists of 16 items rating the quality of each SR as high, moderate, low, or critically low. Two reviewers independently performed the assessments; a third reviewer resolved any disagreement between reviewers.

    Strategy for Data Synthesis

    We followed the methodology outlined in the Cochrane Handbook chapter on overviews of reviews and the JBI Manual for Evidence Synthesis [18]. The characteristics of the included SRs were described with narrative synthesis. The main results reported in the reviews at the shortest follow-up were summarized. Qualitative results reported by the reviews were narratively summarized, while meta-analyzed results were visually presented in terms of directions of effects (favor intervention, no difference between groups, favor control) by a bubble plot map in which bubbles were organized into subgroups based on the AMSTAR 2 assessment, proportional to the number of participants for each meta-analysis and colored by outcomes and population [27].

    Since we expected heterogeneity across reviews due to the different populations, interventions, controls, and outcomes included, the number of overlapping primary studies included in the SRs was not assessed.


    Study Selection

    After removing duplicates, 3598 records were identified. Of the 157 full texts assessed, 122 SRs were excluded and 35 were included. Figure 1 shows the PRISMA flowchart. The reasons for excluding certain studies after reading their full texts are presented in Multimedia Appendix 2 [13-15,28-59], Table S1.

    ‎
    Figure 1. Flow diagram.

    Characteristics of Included SRs

    Most SRs were published in Europe (n=15), followed by the Americas (n=10), Asia (n=7), and Oceania (n=3). The median publication year was 2021 (minimum 2015, maximum 2022), with 77% (n=27) of SRs published in the last 3 years (2020-2022). Most SRs assessed telerehabilitation (n=29). A few assessed digital self-management (n=4) and teleconsultation, telediagnostics, and telemonitoring (n=2). The most common musculoskeletal disorder investigated was osteoarthritis (eg, hip and knee replacement; n=13) and mixed conditions (eg, chronic musculoskeletal pain; n=14). Twenty-two SRs (63%) reported a meta-analysis. More details are reported in Table 1.

    Table 1. General characteristics of included studies (n=35).
    CharacteristicsStudies, n (%)
    Country

    		China6 (17)

    		Spain4 (11)

    		United Kingdom4 (11)

    		United States4 (11)

    		Australia3 (9)

    		Brazil3 (9)

    		Canada3 (9)

    		Finland2 (6)

    		Germany2 (6)

    		Ireland1 (3)

    		Italy1 (3)

    		Netherlands1 (3)

    		Pakistan1 (3)
    Years

    		2020-202227 (77)

    		2017-20197 (20)

    		2014-20161 (3)
    Conflicts of interest

    		No31 (88)

    		Not reported2 (6)

    		Reported2 (6)
    Funding

    		Not reported21 (60)

    		No profit11 (31)

    		Mixed3 (9)
    Population

    		Mixed14 (40)

    		Osteoarthritis13 (37)

    		Other dorsopathies4 (11)

    		Other disorders of the musculoskeletal system and connective tissue3 (9)

    		Autoinflammatory syndromes1 (3)
    Intervention

    		Telerehabilitation29 (83)

    		Digital self-management4 (11)

    		Teleconsultation, telediagnostics, monitoring 2 (6)
    Meta-analysis

    		Yes22 (63)

    		No13 (27)

    Risk of Bias (Quality) Assessment

    Methodological quality was critically low in 69% (n=24) of the SRs, low in 29% (n=10), and moderate in 1. Among critical items, 80% of SRs did not report reasons for exclusion (n=28), 48% did not account for risk of bias in individual studies when interpreting or discussing the results of the review (n=17), and 31% did not carry out an adequate investigation of publication bias (eg, small study bias; n=11). A summary plot is shown in Figure 2 [13-15,28-59].

    ‎
    Figure 2. AMSTAR 2 (A Measurement Tool to Assess systematic Reviews 2) summary plot. Item 1: “Did the research questions and inclusion criteria for the review include the components of PICO?”; item 2: “Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol?”; item 3: “Did the review authors explain their selection of the study designs for inclusion in the review?”; item 4: “Did the review authors use a comprehensive literature search strategy?”; item 5: “Did the review authors perform study selection in duplicate?”; item 6: “Did the review authors perform data extraction in duplicate?”; item 7: “Did the review authors provide a list of excluded studies and justify the exclusions?”; item 8: “Did the review authors describe the included studies in adequate detail?”; item 9: “Did the review authors use a satisfactory technique for assessing the risk of bias RoB in individual studies that were included in the review?”; item 10: “Did the review authors report on the sources of funding for the studies included in the review?”; item 11: “If meta-analysis was performed, did the review authors use appropriate methods for statistical combination of results?”; item 12: “If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis?”; item 13: “Did the review authors account for RoB in primary studies when interpreting/discussing the results of the review?”; item 14: “Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review?”; item 15: “If they performed quantitative synthesis did the review authors carry out an adequate investigation of publication bias small study bias and discuss its likely impact on the results of the review?”; item 16: “Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?”.

    Outcome Characteristics

    Overall, 190 outcomes were collected, among which were 142 PROMs and 15 PREMs; 31 objective outcomes were also collected, including 19 related to physical function, 4 to physical activity (eg, steps per day), and 8 to costs; 2 were composite outcomes (ie, PROMs plus objective measures). The most reported PROMs were related to pain assessment (n=40 in 29 reviews), physical function (n=35 in 27 reviews), and HRQoL (n=20 in 20 reviews). Among PREMs, technology was assessed in 4 reviews (11%) and treatment in 8 reviews (23%). Figure 3 illustrates the outcomes assessed by the reviews in subgroup for PROMs, PREMs, and objective measures.

    ‎
    Figure 3. Outcomes reported by reviews. The frequencies of each outcome category reflect the number of reviews addressing them. Inner circles represent the 3 categories defined in the methods: objective outcomes, patient-reported outcome measures (PROMs), and patient-reported experience measures (PREMs); outer circles represent the outcome domains (eg, physical function). HrQoL: health-related quality of life.

    Summary of Quantitative Analyses

    A total of 23 reviews (66%) reported a meta-analysis for a total of 79 analyses. Among these, 60 meta-analyses were performed on PROMs, 4 on PREMs, 13 on objective outcomes, and 2 on composite outcomes (ie, PROMs plus objective measurements).

    Most PROMs were quantitatively analyzed in the following categories: pain assessment (n=23), physical function (n=21), HRQoL (n=8), cognitive function (n=2), emotional function (n=4), health literacy (n=1), and social function (n=1). The 37% (n=22) of meta-analyses assessing PROMs had results favoring telemedicine, 58% (n=35) found no differences between groups, and a few favored controls (n=3). No quantitative analyses for side effects or adherence were found. Meta-analyses of PREMs analyzed only treatment experiences and none showed any difference between groups. All the 13 objective outcomes meta-analyzed were on physical function (eg, balance test, Time Up and Go test, range of motion, 6-minute walking test), mainly favoring telemedicine (n=2) or showing no differences between groups (n=7), while a few (n=4) favored controls. Composite outcomes including PROMs and objective measures were analyzed in 2 meta-analyses; these showed no differences between groups. Overall, reported heterogeneity ranged from 0 to 97 (median I2 28.2, IQR 0-67.8)

    Figure 4 represents, with bubble plots, the direction of results and methodological quality of reviews in subgroups for outcome categories and populations.

    ‎
    Figure 4. Bubble plot showing directions of effects and AMSTAR 2 (A Measurement Tool to Assess systematic Reviews 2) results by (A) outcomes and (B) type of population. This graphic provides information in three dimensions: (1) in the x-axis, the authors’ conclusions are rated as “beneficial for intervention,” “no effect,” or “beneficial for control” (this is further described in the Data Extraction section); (2) in the y-axis, the quality assessment (AMSTAR 2) is shown; and (3) the bubble size is proportional to the number of participants included in each systematic review. PREM: patient-reported outcome measure; PROM: patient-reported experience measure.

    Summary of Qualitative Analyses

    Twenty-four SRs reported qualitative results. Overall, 82 PROMs were described in the following areas: pain assessment (n=16), physical function (n=14), HRQoL (n=13), health literacy (n=9), cognitive function (n=8), side effects (n=8), adherence (n=7), emotional function (n=4), and social function (n=3). The SRs reported heterogeneous results in terms of physical function and HRQoL. Most of the SRs reported beneficial results in terms of health literacy and cognitive function in favor of telemedicine intervention, that is, the effects of the experimental intervention were superior or equal to control in all other outcomes. Eight of the 12 PREMs included by the SRs were related to treatment and 4 to technology; 9 of the 21 objective outcomes were related to physical function, 4 to physical activity, and 8 to costs. Considering costs, all SRs showed that telemedicine cost significantly less than in-person visits or usual care. Multimedia Appendix 3 qualitatively describes these outcomes divided by domain of interest.


    Main Findings

    This umbrella review summarizes the results from 35 SRs on telemedicine for musculoskeletal disorders, mainly published in the last 3 years (2020-2022) and predominantly conducted in Europe and North America. The type of telemedicine most often assessed was telerehabilitation for mixed chronic musculoskeletal pain and osteoarthritis. Overall, we retrieved many PROMs assessing pain, physical function, and HRQoL, whereas PREMs were less investigated.

    According to our results, PROMs are more frequently analyzed than objective measures and PREMs, with most meta-analyses showing an improvement or similar effects compared to any other kind of intervention (eg, in-person treatment, usual care, or waiting list). The same effects were found in different subgroups of populations when visualized by direction of effects. However, some PROMs, such as side effects and adherence, were not quantitatively analyzed. It can be hypothesized that primary studies did not offer useful data to be pooled in a synthesis due to different taxonomies or poor outcome reporting, as well as the presence of outcome nonreporting bias [60,61].

    Narrative syntheses on PREMs were reported in few SRs. Superior or equal effects were reported by telemedicine interventions in terms of acceptability of technology (usability, enjoyment, patient experience) and beneficial effects in terms of treatment (patient satisfaction and motivation). Costs were poorly investigated, but it seems that direct and indirect costs were reduced when telemedicine intervention is provided in comparison to in-person visits or usual care.

    Overall, SR results should be interpreted with caution considering their methodological quality, which was generally critically low.

    Comparison With Previous Overviews

    Our findings are consistent with a previous overview [62] on the use of telemedicine across the 53 member states of the World Health Organization European Region, which showed clear benefits of telemedicine interventions in the screening, diagnosis, management, treatment, and long-term follow-up of many clinically and epidemiologically relevant diseases. Other overviews found that telemedicine delivered in different forms (eg, telerehabilitation, teleconsultation, and telemonitoring) has the potential to improve clinical outcomes in patients with cardiovascular disease [63] and chronic obstructive respiratory diseases [64]; patients who have survived cancer [65]; patients requiring neurorehabilitation [66] or urology care [67]; and patients with diabetes, dyslipidemia, and hypertension [68]. However, there are some areas of intervention that have not yet been covered by telemedicine and have uncertain effectiveness [68]. Nevertheless, in the musculoskeletal field, our umbrella review agrees with a previous study that supported the use of devices, tools, or software applications to facilitate remote rehabilitation and health care in general [69].

    Clinical Implications

    Clinicians and stakeholders should consider the adoption of the best available telemedicine technologies to treat patients’ acute and chronic conditions, both in ordinary [70] and extraordinary situations [71]; evidence-based exercise and education [72] can be tailored and delivered remotely, for instance, to increase patients’ compliance to treatment [28,73], reduce withdrawal rates from follow-up (so-called no-show patients), optimize workforce efficiency [74], and sometimes reduce health care costs [75].

    Patient-centered care builds on the consideration of individual preference, easier access to treatment, and digital literacy enhancement. However, several barriers still exist in terms of ethical issues, privacy, accessibility, and data security. Telemedicine may help reach people living and working in rural and remote areas [76] with limited medical facilities and personnel. Indeed, patients living in rural areas can have poorer health outcomes in comparison to their urban counterparts [77], highlighting unequal health coverage [78]. An equal use of telemedicine technologies needs countries to invest in effective information policies and communication infrastructures [79]. One example is an Australian Commonwealth government program that aims to expand the Medical Benefit Schedule (MBS) by including telephone or online health consultations to reduce inequalities in favor of rural or remote patients.

    Research Implications

    Further efforts should be pursued to standardize collection of PROMs and PREMs in studies evaluating telemedicine. One significant challenge for certain musculoskeletal conditions is the lack of uniformity in outcome measurement across clinical trials; better standardization might help to identify and include PROMs and PREMs in core outcome sets to be measured and reported in all trials of a specific condition [80]. At present, for musculoskeletal disorders, there is still no clear consensus on PROMs as a core outcome set, even though some sets have been developed for Norway and the United Kingdom. Future research is needed to validate these in other countries [81,82].

    Considering the lack of evidence on the use of PREMs in the evaluation of telemedicine technologies, they should be used more frequently and consistently before and after interventions. Few SRs reported data regarding costs, which is worth studying in more detail, taking into account the comparative difficulties related to different health care systems [83] and the different means of economic evaluation generally adopted [6,84].

    Currently, research is ongoing to identify common core outcome domains from core outcome sets of musculoskeletal conditions [85].

    Strengths and Limitations

    To our knowledge, this is the first umbrella review encompassing any kind of telemedicine for different musculoskeletal disorders, including multiple clinical outcomes and costs.

    However, some limitations should be mentioned. Only 2 databases were explored and some relevant SRs from other sources (eg, gray literature) may have been missed. Inclusion criteria were focused on SRs of RCTs only. This criterion might have influenced the ratio of PROMs to PREMs, as this may depend on the study type and evidence level [8]. In fact, a previous study [8] investigating the use of PROMs and PREMs in any population with a telemedicine prescription found that the frequency of PREMs decreased with an increasing evidence level (ie, RCTs). Nevertheless, RCTs and reports with the highest quality of evidence should also include information on the usability and acceptance of the technology, expressed as PREMs, in addition to PROMs.

    Moreover, we collected and interpreted quantitative effects in the SRs only at the shortest follow-up, limiting generalizability to all time end points. As well, it is possible that the overall positive effects might be biased by the wide range of heterogeneity within the included meta-analyses.

    Finally, published taxonomies were used to standardize populations, interventions, and outcomes; however, the categorization of interventions was made difficult by the heterogeneous definition of telemedicine given by the SRs (ie, some used hybrid telemedicine or telemedicine mixed with conventional care, some did not; some used synchronous telemedicine, some did not). Indeed, telemedicine is considered an umbrella term for all health care services [1,2].

    Conclusion

    Telemedicine for musculoskeletal conditions can provide more accessible health care, with noninferior results in multiple clinical outcomes and no increase in side effects in comparison with more conventional care. The assessment of telemedicine is largely represented by PROMs, reflecting the relevance of patient-centered care. From a cost-effectiveness point of view, future studies should put effort into investigating PREMs, objective measures, and costs, filling the gaps in this promising area.

    Acknowledgments

    We thank our MSc (master of science) students, Gaia Ravot and Paolo Caneparo, for supporting us in the assessment of the methodological quality of the systematic reviews. This study was funded by the Italian Ministry of Health (Ricerca Corrente L3054), which had no role in the study design, data collection, analysis, interpretation, or report writing. The article processing charge was funded by the Italian Ministry of Health (Ricerca Corrente). This research did not receive a specific grant from any funding agency in the public, commercial or not-for-profit sectors.

    Data Availability

    The data sets generated during and/or analyzed during this study are available in the Open Science Framework repository [86].

    Authors' Contributions

    S Gianola and SB conceptualized and designed the study, drafted the initial manuscript, and coordinated and supervised the data collection. FP conceptualized the study and selected and collected data. GC performed the statistical analysis and contributed to results interpretation. S Guida selected and collected data and reviewed the manuscript. JAV and GB contributed to results interpretation and reviewed the manuscript. All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work.

    Conflicts of Interest

    None declared.

    Multimedia Appendix 1

    Search strategy, taxonomy, and methodological quality assessment.

    DOCX File , 25 KB
    Multimedia Appendix 2

    List of included and excluded studies, general characteristics of included systematic reviews, and effect sizes.

    DOCX File , 79 KB
    Multimedia Appendix 3

    Narrative synthesis of patient-reported outcomes and experiences.

    DOCX File , 35 KB
    Multimedia Appendix 4

    PRISMA checklist.

    PDF File (Adobe PDF File), 72 KB
    1. Cottrell MA, Russell TG. Telehealth for musculoskeletal physiotherapy. Musculoskelet Sci Pract. Aug 2020;48:102193. [FREE Full text] [CrossRef] [Medline]
    2. Russell TG. Physical rehabilitation using telemedicine. J Telemed Telecare. 2007;13(5):217-220. [CrossRef] [Medline]
    3. Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence. BMC Public Health. Aug 01, 2020;20(1):1193. [FREE Full text] [CrossRef] [Medline]
    4. Bordas-Martinez J, Matéu Gómez L, Cámara Menoyo D, López-Sánchez M, Santos S, Molina-Molina M, et al. Patient-reported outcomes measures (PROMs) and patient-reported experience measures (PREMs) of COVID-19 telerehabilitation: Prospective pilot program. Medicine (Baltimore). Aug 05, 2022;101(31):e29639. [FREE Full text] [CrossRef] [Medline]
    5. Foni NO, Costa LAV, Velloso LMR, Pedrotti CHS. Telemedicine: Is it a tool for orthopedics? Curr Rev Musculoskelet Med. Dec 2020;13(6):797-801. [FREE Full text] [CrossRef] [Medline]
    6. Vanni F, Foglia E, Pennestrì F, Ferrario L, Banfi G. Introducing enhanced recovery after surgery in a high-volume orthopaedic hospital: a health technology assessment. BMC Health Serv Res. Aug 24, 2020;20(1):773. [FREE Full text] [CrossRef] [Medline]
    7. Rogante M, Grigioni M, Cordella D, Giacomozzi C. Ten years of telerehabilitation: A literature overview of technologies and clinical applications. NeuroRehabilitation. 2010;27(4):287-304. [CrossRef] [Medline]
    8. Knapp A, Harst L, Hager S, Schmitt J, Scheibe M. Use of patient-reported outcome measures and patient-reported experience measures within evaluation studies of telemedicine applications: systematic review. J Med Internet Res. Nov 17, 2021;23(11):e30042. [FREE Full text] [CrossRef] [Medline]
    9. Jamieson Gilmore K, Corazza I, Coletta L, Allin S. The uses of patient reported experience measures in health systems: a systematic narrative review. Health Policy. Feb 2023;128:1-10. [FREE Full text] [CrossRef] [Medline]
    10. De Rosis S, Cerasuolo D, Nuti S. Using patient-reported measures to drive change in healthcare: the experience of the digital, continuous and systematic PREMs observatory in Italy. BMC Health Serv Res. Apr 16, 2020;20(1):315. [FREE Full text] [CrossRef] [Medline]
    11. Corazza I, Gilmore KJ, Menegazzo F, Abols V. Benchmarking experience to improve paediatric healthcare: listening to the voices of families from two European children's university hospitals. BMC Health Serv Res. Jan 27, 2021;21(1):93. [FREE Full text] [CrossRef] [Medline]
    12. Pennestrì F, Banfi G. The experience of patients in chronic care management: applications in health technology assessment (HTA) and value for public health. Int J Environ Res Public Health. Aug 10, 2022;19(16):9868. [FREE Full text] [CrossRef] [Medline]
    13. Jiang S, Xiang J, Gao X, Guo K, Liu B. The comparison of telerehabilitation and face-to-face rehabilitation after total knee arthroplasty: a systematic review and meta-analysis. J Telemed Telecare. May 2018;24(4):257-262. [CrossRef] [Medline]
    14. Du S, Liu W, Cai S, Hu Y, Dong J. The efficacy of e-health in the self-management of chronic low back pain: A meta analysis. Int J Nurs Stud. Jun 2020;106:103507. [CrossRef] [Medline]
    15. McDonnell J, Ahern D, Ross T, Gibbons D, Synnott K, Butler J. The efficacy of remote virtual care in comparison to traditional clinical visits for elective orthopaedic patients: A meta-analysis of prospective randomised controlled trials. Surgeon. Jun 2022;20(3):177-186. [CrossRef] [Medline]
    16. Belbasis L, Bellou V, Ioannidis JPA. Conducting umbrella reviews. BMJ Med. 2022;1(1):e000071. [FREE Full text] [CrossRef] [Medline]
    17. Aromataris E, Fernandez R, Godfrey C, Holly C, Khalil H, Bhatarasakoon P. JBI Reviewer's Manual, Chapter 10: Umbrella Reviews. Joanna Briggs Institute. URL: https:/​/jbi-global-wiki.​refined.site/​space/​MANUAL/​4685848/​Previous+versions?attachment=/​rest/​api/​content/​4685848/​child/​attachment/​att4698146/​download&type=application/​pdf&filename=JBI_Reviewers_Manual_2020March [accessed 2023-12-27]
    18. Pollock M, Fernandes R, Becker L, Pieper D, Hartling L. Cochrane Handbook for Systematic Reviews of Interventions Handbook, Part 1, Chapter V: Overviews of Reviews. Wiley Online Library. URL: https://onlinelibrary.wiley.com/doi/10.1002/9780470712184.ch22 [accessed 2023-12-27]
    19. Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. Mar 29, 2021;372:n71. [FREE Full text] [CrossRef] [Medline]
    20. Pollock M, Fernandes RM, Pieper D, Tricco AC, Gates M, Gates A, et al. Preferred Reporting Items for Overviews of Reviews (PRIOR): a protocol for development of a reporting guideline for overviews of reviews of healthcare interventions. Syst Rev. Dec 23, 2019;8(1):335. [FREE Full text] [CrossRef] [Medline]
    21. Gates M, Gates A, Pieper D, Fernandes RM, Tricco AC, Moher D, et al. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. Aug 09, 2022;378:e070849. [FREE Full text] [CrossRef] [Medline]
    22. About Cochrane reviews. Cochrane Library. URL: https://www.cochranelibrary.com/about/about-cochrane-reviews [accessed 2022-01-28]
    23. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. Feb 15, 2007;7:10. [FREE Full text] [CrossRef] [Medline]
    24. Rethlefsen M, Kirtley S, Waffenschmidt S, Ayala A, Moher D, Page M, et al. PRISMA-S Group. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev. Jan 26, 2021;10(1):39. [FREE Full text] [CrossRef] [Medline]
    25. ICD-10-CM codes M00-M99: diseases of the musculoskeletal system and connective tissue. ICD10data. URL: https://www.icd10data.com/ICD10CM/Codes/M00-M99 [accessed 2023-12-27]
    26. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. Sep 21, 2017;358:j4008. [FREE Full text] [CrossRef] [Medline]
    27. Miake-Lye IM, Mak S, Lee J, Luger T, Taylor SL, Shanman R, et al. Massage for pain: an evidence map. J Altern Complement Med. May 2019;25(5):475-502. [FREE Full text] [CrossRef] [Medline]
    28. Adamse C, Dekker-Van Weering MG, van Etten-Jamaludin FS, Stuiver MM. The effectiveness of exercise-based telemedicine on pain, physical activity and quality of life in the treatment of chronic pain: A systematic review. J Telemed Telecare. Sep 2018;24(8):511-526. [CrossRef] [Medline]
    29. Agostini M, Moja L, Banzi R, Pistotti V, Tonin P, Venneri A, et al. Telerehabilitation and recovery of motor function: a systematic review and meta-analysis. J Telemed Telecare. Jun 2015;21(4):202-213. [FREE Full text] [CrossRef] [Medline]
    30. Chaudhry H, Nadeem S, Mundi R. How satisfied are patients and surgeons with telemedicine in orthopaedic care during the COVID-19 pandemic? a systematic review and meta-analysis. Clin Orthop Relat Res. Jan 01, 2021;479(1):47-56. [FREE Full text] [CrossRef] [Medline]
    31. Chen T, Or CK, Chen J. Effects of technology-supported exercise programs on the knee pain, physical function, and quality of life of individuals with knee osteoarthritis and/or chronic knee pain: A systematic review and meta-analysis of randomized controlled trials. J Am Med Inform Assoc. Feb 15, 2021;28(2):414-423. [FREE Full text] [CrossRef] [Medline]
    32. Cuenca-Martínez F, López-Bueno L, Suso-Martí L, Varangot-Reille C, Calatayud J, Herranz-Gómez A, et al. Implementation of online behavior modification techniques in the management of chronic musculoskeletal pain: a systematic review and meta-analysis. J Clin Med. Mar 24, 2022;11(7):1806. [FREE Full text] [CrossRef] [Medline]
    33. Cuenca-Martínez F, Suso-Martí L, Herranz-Gómez A, Varangot-Reille C, Calatayud J, Romero-Palau M, et al. Effectiveness of telematic behavioral techniques to manage anxiety, stress and depressive symptoms in patients with chronic musculoskeletal pain: a systematic review and meta-analysis. Int J Environ Res Public Health. Mar 09, 2022;19(6):3231. [FREE Full text] [CrossRef] [Medline]
    34. Cuevas-Lara C, Izquierdo M, Sáez de Asteasu ML, Ramírez-Vélez R, Zambom-Ferraresi F, Zambom-Ferraresi F, et al. Impact of game-based interventions on health-related outcomes in hospitalized older patients: a systematic review. J Am Med Dir Assoc. Feb 2021;22(2):364-371.e1. [CrossRef] [Medline]
    35. Dias JF, Oliveira VC, Borges PRT, Dutra FCMS, Mancini MC, Kirkwood RN, et al. Effectiveness of exercises by telerehabilitation on pain, physical function and quality of life in people with physical disabilities: a systematic review of randomised controlled trials with GRADE recommendations. Br J Sports Med. Feb 2021;55(3):155-162. [CrossRef] [Medline]
    36. Esfandiari E, Miller WC, Berardi A, King S, Ashe MC. Telehealth interventions for mobility after lower limb loss: a systematic review and meta-analysis of randomized controlled trials. Prosthet Orthot Int. Apr 01, 2022;46(2):108-120. [CrossRef] [Medline]
    37. Fritsch CG, Ferreira PH, Prior JL, McLachlan AJ, Ferreira ML. Effects of using text message interventions for the management of musculoskeletal pain: a systematic review. Pain. Nov 2020;161(11):2462-2475. [CrossRef] [Medline]
    38. Gava V, Ribeiro LP, Barreto RPG, Camargo PR. Effectiveness of physical therapy given by telerehabilitation on pain and disability of individuals with shoulder pain: a systematic review. Clin Rehabil. Jun 2022;36(6):715-725. [CrossRef] [Medline]
    39. Gazendam A, Zhu M, Chang Y, Phillips S, Bhandari M. Virtual reality rehabilitation following total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. Knee Surg Sports Traumatol Arthrosc. Aug 2022;30(8):2548-2555. [FREE Full text] [CrossRef] [Medline]
    40. Hewitt S, Sephton R, Yeowell G. The effectiveness of digital health interventions in the management of musculoskeletal conditions: systematic literature review. J Med Internet Res. Jun 05, 2020;22(6):e15617. [FREE Full text] [CrossRef] [Medline]
    41. Jansson MM, Hyvämäki P, Pikkarainen M. Computer- and telephone-delivered interventions on patient outcomes and resource utilization in patients with orthopaedic conditions: a systematic review and narrative synthesis. Orthop Nurs. 2020;39(5):340-352. [CrossRef] [Medline]
    42. Jansson MM, Rantala A, Miettunen J, Puhto AP, Pikkarainen M. The effects and safety of telerehabilitation in patients with lower-limb joint replacement: a systematic review and narrative synthesis. J Telemed Telecare. Feb 2022;28(2):96-114. [CrossRef] [Medline]
    43. Lara-Palomo IC, Gil-Martínez E, Ramírez-García JD, Capel-Alcaraz AM, García-López H, Castro-Sánchez AM, et al. Efficacy of e-health interventions in patients with chronic low-back pain: a systematic review with meta-analysis. Telemed J E Health. Dec 2022;28(12):1734-1752. [CrossRef] [Medline]
    44. Latif-Zade T, Tucci B, Verbovetskaya D, Bialkin E, Ng B, Heddon S, et al. Systematic review shows tele-rehabilitation might achieve comparable results to office-based rehabilitation for decreasing pain in patients with knee osteoarthritis. Medicina (Kaunas). Jul 28, 2021;57(8):764. [FREE Full text] [CrossRef] [Medline]
    45. Lin H, Han K, Ruan B. Effect of virtual reality on functional ankle instability rehabilitation: a systematic review. J Healthc Eng. 2021;2021:7363403. [FREE Full text] [CrossRef] [Medline]
    46. Master H, Bley JA, Coronado RA, Robinette PE, White DK, Pennings JS, et al. Effects of physical activity interventions using wearables to improve objectively-measured and patient-reported outcomes in adults following orthopaedic surgical procedures: A systematic review. PLoS One. 2022;17(2):e0263562. [FREE Full text] [CrossRef] [Medline]
    47. McHugh CG, Kostic AM, Katz JN, Losina E. Effectiveness of remote exercise programs in reducing pain for patients with knee osteoarthritis: A systematic review of randomized trials. Osteoarthr Cartil Open. Sep 2022;4(3):100264. [FREE Full text] [CrossRef] [Medline]
    48. Nicholl BI, Sandal LF, Stochkendahl MJ, McCallum M, Suresh N, Vasseljen O, et al. Digital support interventions for the self-management of low back pain: a systematic review. J Med Internet Res. May 21, 2017;19(5):e179. [FREE Full text] [CrossRef] [Medline]
    49. Oliveira CB, Franco MR, Maher CG, Ferreira PH, Morelhão PK, Damato TM, et al. Physical activity-based interventions using electronic feedback may be ineffective in reducing pain and disability in patients with chronic musculoskeletal pain: a systematic review with meta-analysis. Arch Phys Med Rehabil. Sep 2018;99(9):1900-1912. [CrossRef] [Medline]
    50. Petersen W, Karpinski K, Backhaus L, Bierke S, Häner M. A systematic review about telemedicine in orthopedics. Arch Orthop Trauma Surg. Oct 2021;141(10):1731-1739. [FREE Full text] [CrossRef] [Medline]
    51. Safari R, Jackson J, Sheffield D. Digital self-management interventions for people with osteoarthritis: systematic review with meta-analysis. J Med Internet Res. Jul 20, 2020;22(7):e15365. [FREE Full text] [CrossRef] [Medline]
    52. Schäfer AGM, Zalpour C, von Piekartz H, Hall TM, Paelke V. The efficacy of electronic health-supported home exercise interventions for patients with osteoarthritis of the knee: systematic review. J Med Internet Res. Apr 26, 2018;20(4):e152. [FREE Full text] [CrossRef] [Medline]
    53. Srikesavan C, Bryer C, Ali U, Williamson E. Web-based rehabilitation interventions for people with rheumatoid arthritis: a systematic review. J Telemed Telecare. Jun 2019;25(5):263-275. [CrossRef] [Medline]
    54. Tabacof L, Baker TS, Durbin JR, Desai V, Zeng Q, Sahasrabudhe A, et al. Telehealth treatment for nonspecific low back pain: a review of the current state in mobile health. PM R. Sep 2022;14(9):1086-1098. [CrossRef] [Medline]
    55. Tsang MP, Man GCW, Xin H, Chong YC, Ong MTY, Yung PSH. The effectiveness of telerehabilitation in patients after total knee replacement: a systematic review and meta-analysis of randomized controlled trials. J Telemed Telecare. May 12, 2022:1357633X221097469. [CrossRef] [Medline]
    56. Wang Q, Lee RLT, Hunter S, Chan SWC. The effectiveness of internet-based telerehabilitation among patients after total joint arthroplasty: a systematic review and meta-analysis of randomised controlled trials. J Telemed Telecare. May 2023;29(4):247-260. [CrossRef] [Medline]
    57. Wang X, Hunter DJ, Vesentini G, Pozzobon D, Ferreira ML. Technology-assisted rehabilitation following total knee or hip replacement for people with osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. Nov 03, 2019;20(1):506. [FREE Full text] [CrossRef] [Medline]
    58. Xie SH, Wang Q, Wang LQ, Wang L, Song KP, He CQ. Effect of internet-based rehabilitation programs on improvement of pain and physical function in patients with knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Med Internet Res. Jan 05, 2021;23(1):e21542. [CrossRef] [Medline]
    59. Hussain A, Haroon H, Ahmed A, Gilani SA. Digital technologies in management of chronic pain - a systematic review. J Pak Med Assoc. Jun 2022;72(6):1158-1165. [FREE Full text] [CrossRef] [Medline]
    60. Page MJ, Higgins JPT. Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study. Syst Rev. Jul 08, 2016;5(1):108. [FREE Full text] [CrossRef] [Medline]
    61. McGauran N, Wieseler B, Kreis J, Schüler YB, Kölsch H, Kaiser T. Reporting bias in medical research - a narrative review. Trials. Apr 13, 2010;11(1):37. [FREE Full text] [CrossRef] [Medline]
    62. Saigí-Rubió F, Borges do Nascimento IJ, Robles N, Ivanovska K, Katz C, Azzopardi-Muscat N, et al. The current status of telemedicine technology use across the World Health Organization European region: an overview of systematic reviews. J Med Internet Res. Oct 27, 2022;24(10):e40877. [FREE Full text] [CrossRef] [Medline]
    63. Arian M, Valinejadi A, Soleimani M. Quality of life in heart patients receiving telerehabilitation: an overview with meta-analyses. Iran J Public Health. Nov 2022;51(11):2388-2403. [FREE Full text] [CrossRef] [Medline]
    64. Barbosa MT, Sousa CS, Morais-Almeida M. Telemedicine in the management of chronic obstructive respiratory diseases: an overview. Exon Publications. URL: https://www.ncbi.nlm.nih.gov/books/NBK580636/ [accessed 2023-12-27]
    65. Chan R, Crichton M, Crawford-Williams F, Agbejule O, Yu K, Hart N, et al. Multinational Association of Supportive Care in Cancer (MASCC) Survivorship Study Group. The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews. Ann Oncol. Dec 2021;32(12):1552-1570. [FREE Full text] [CrossRef] [Medline]
    66. Matamala-Gomez M, Bottiroli S, Realdon O, Riva G, Galvagni L, Platz T, et al. Telemedicine and virtual reality at time of COVID-19 pandemic: an overview for future perspectives in neurorehabilitation. Front Neurol. 2021;12:646902. [FREE Full text] [CrossRef] [Medline]
    67. Ellimoottil C. Implementing telemedicine in urology: an overview of the benefits and barriers. J Urol. Jul 2019;202(1):47-48. [CrossRef] [Medline]
    68. Timpel P, Oswald S, Schwarz PEH, Harst L. Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension: an umbrella review of systematic reviews and meta-analyses. J Med Internet Res. Mar 18, 2020;22(3):e16791. [FREE Full text] [CrossRef] [Medline]
    69. Edwards D, Williams J, Carrier J, Davies J. Technologies used to facilitate remote rehabilitation of adults with deconditioning, musculoskeletal conditions, stroke, or traumatic brain injury: an umbrella review. JBI Evid Synth. Aug 01, 2022;20(8):1927-1968. [CrossRef] [Medline]
    70. Baroni MP, Jacob MFA, Rios WR, Fandim JV, Fernandes LG, Chaves PI, et al. The state of the art in telerehabilitation for musculoskeletal conditions. Arch Physiother. Jan 04, 2023;13(1):1. [FREE Full text] [CrossRef] [Medline]
    71. Pennestrì F, Gaudioso A, Jani A, Bottinelli E, Banfi G. Is administered competition suitable for dealing with a public health emergency? Lessons from the local healthcare system at the centre of early COVID-19 outbreak in Italy. Cent Eur J Public Health. Jun 2021;29(2):109-116. [FREE Full text] [CrossRef] [Medline]
    72. de Campos TF. Low back pain and sciatica in over 16s: assessment and management NICE Guideline [NG59]. J Physiother. Apr 2017;63(2):120. [FREE Full text] [CrossRef] [Medline]
    73. Morrison KS, Paterson C, Toohey K. The feasibility of exercise interventions delivered via telehealth for people affected by cancer: a rapid review of the literature. Semin Oncol Nurs. Dec 2020;36(6):151092. [CrossRef] [Medline]
    74. Bhavsar NA, Doerfler SM, Giczewska A, Alhanti B, Lutz A, Thigpen CA, et al. Prevalence and predictors of no-shows to physical therapy for musculoskeletal conditions. PLoS One. 2021;16(5):e0251336. [FREE Full text] [CrossRef] [Medline]
    75. Snoswell CL, Taylor ML, Comans TA, Smith AC, Gray LC, Caffery LJ. Determining if telehealth can reduce health system costs: scoping review. J Med Internet Res. Oct 19, 2020;22(10):e17298. [FREE Full text] [CrossRef] [Medline]
    76. Balestri R, Cavina E, Aliferis A, Goletti O, Rocci R, Lippolis PV, et al. Telemedicine on a small island. J Telemed Telecare. 1999;5 Suppl 1(1_suppl):S50-S52. [CrossRef] [Medline]
    77. Wakerman J, Humphreys JS. Sustainable primary health care services in rural and remote areas: innovation and evidence. Aust J Rural Health. Jun 2011;19(3):118-124. [CrossRef] [Medline]
    78. Bradford N, Caffery L, Smith A. Telehealth services in rural and remote Australia: a systematic review of models of care and factors influencing success and sustainability. Rural Remote Health. 2016;16(4):4268. [FREE Full text] [Medline]
    79. Meso P, Mbarika V, Sood S. An overview of potential factors for effective telemedicine transfer to sub-Saharan Africa. IEEE Trans Inf Technol Biomed. Sep 2009;13(5):734-739. [CrossRef] [Medline]
    80. Macefield RC, Jacobs M, Korfage IJ, Nicklin J, Whistance RN, Brookes ST, et al. Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs). Trials. Feb 05, 2014;15(1):49. [FREE Full text] [CrossRef] [Medline]
    81. Burgess R, Lewis M, McRobert C, Hill J. Developing a core outcome set for community and primary care musculoskeletal services: A consensus approach. Musculoskelet Sci Pract. Oct 2021;55:102415. [CrossRef] [Medline]
    82. Klokkerud M, Dagfinrud H, Uhlig T, Dager T, Furunes K, Klokkeide; et al. Developing and testing a consensus-based core set of outcome measures for rehabilitation in musculoskeletal diseases. Scand J Rheumatol. May 2018;47(3):225-234. [CrossRef] [Medline]
    83. Lim KK, Chan M, Navarra S, Haq SA, Lau CS. Development and implementation of models of care for musculoskeletal conditions in middle-income and low-income Asian countries. Best Pract Res Clin Rheumatol. Jun 2016;30(3):398-419. [CrossRef] [Medline]
    84. Pennestrì F, Lega F, Banfi G. From volume to value: Improving peri-operative elective pathways through a roadmap from fast-track orthopedic surgery. Health Serv Manage Res. Nov 2023;36(4):284-290. [FREE Full text] [CrossRef] [Medline]
    85. Sabet TS, Anderson DB, Stubbs PW, Buchbinder R, Terwee CB, Chiarotto A, et al. Identifying common core outcome domains from core outcome sets of musculoskeletal conditions: protocol for a systematic review. Syst Rev. Nov 19, 2022;11(1):248. [FREE Full text] [CrossRef] [Medline]
    86. Efficacy of telemedicine for musculoskeletal disorders: an umbrella review. OSFHome. URL: https://osf.io/pxedm [accessed 2023-12-27]

    ‎
    AMSTAR 2: A Measurement Tool to Assess systematic Reviews 2
    HRQoL: health-related quality of life
    ICD-10: International Classification of Diseases, 10th revision
    MD: mean difference SMD: standardized mean difference
    OR: odds ratio
    PICOS: population, intervention, comparison, outcomes, study design
    PREM: patient-reported experience measure
    PRIOR: Preferred Reporting Items for Overviews of Reviews
    PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
    PROM: patient-reported outcome measure
    PROSPERO: Prospective Register of Systematic Reviews
    RCT: randomized controlled trial
    RR: relative risk
    SR: systematic review

    Edited by T de Azevedo Cardoso; submitted 19.06.23; peer-reviewed by L Harst, N Shah; comments to author 13.10.23; revised version received 02.11.23; accepted 29.11.23; published 02.02.24.

    Copyright

    ©Silvia Bargeri, Greta Castellini, Jacopo Antonino Vitale, Stefania Guida, Giuseppe Banfi, Silvia Gianola, Federico Pennestrì. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 02.02.2024.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.